CA Stock MarketDetailed Quotes
IPCI IntelliPharmaCeutics International Inc
- 0.080
- 0.0000.00%
15min DelayMarket Closed Mar 25 16:00 ET
2.65MMarket Cap-655P/E (TTM)
0.000High0.000Low0Volume0.000Open0.080Pre Close0.00Turnover0.12552wk High0.00%Turnover Ratio33.09MShares0.06052wk Low-0.122EPS TTM2.60MFloat Cap188.500Historical HighLossP/E (Static)32.51MShs Float0.040Historical Low-0.121EPS LYR0.00%Amplitude--Dividend TTM-0.15P/B1Lot Size--Div YieldTTM
IntelliPharmaCeutics International Inc Key Stats
EPS
According to the latest financial report of IntelliPharmaCeutics International Inc, the latest earnings per share (TTM) for the company is -0.06. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about IntelliPharmaCeutics International Inc's free cash flow? The latest report shows it as 240.83K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of IntelliPharmaCeutics International Inc shows that the company's current ratio is 0.06, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of IntelliPharmaCeutics International Inc, the quick ratio is 0.05, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of IntelliPharmaCeutics International Inc? The latest ROE figure is -128.75%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of IntelliPharmaCeutics International Inc, the total asset return on investment (ROA) is -114.46%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check IntelliPharmaCeutics International Inc's latest financial report to see how their gross margin is doing - currently at 74.64%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of IntelliPharmaCeutics International Inc, the net profit margin is -2.68K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data